Current management strategies of acute post-operative endophthalmitis

Seminars in Ophthalmology

Volumn 18, Issue 3, 2003, Pages 109-115

  Das, Taraprasad ^a   Sharma, Savitri ^a  

^a L V PRASAD EYE INSTITUTE   (India)

Author keywords

Acute; Bacterial; Cataract surgery; Endophthalmitis; EVS

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; ATROPINE; CEFAZOLIN; CEFTAZIDIME; CIPROFLOXACIN; CORTICOSTEROID; DEXAMETHASONE; GATIFLOXACIN; GENTAMICIN; OFLOXACIN; PREDNISOLONE ACETATE; PREDNISONE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ANTIBIOTIC THERAPY; BACTERIAL INFECTION; DEVELOPING COUNTRY; ENDOPHTHALMITIS; EYE TOXICITY; HUMAN; LENS IMPLANT; MICROBIAL CONTAMINATION; PRIORITY JOURNAL; RETINA DISEASE; REVIEW; SIDE EFFECT; SYSTEMIC THERAPY; VITRECTOMY;

ACUTE DISEASE; ADRENAL CORTEX HORMONES; ANTI-BACTERIAL AGENTS; ENDOPHTHALMITIS; HUMANS; OPHTHALMOLOGIC SURGICAL PROCEDURES; TREATMENT OUTCOME; VITRECTOMY;

EID: 1642564281     PISSN: 08820538     EISSN: None     Source Type: Journal    
DOI: 10.1076/soph.18.3.109.29804     Document Type: Review

References (35)

1. Kresloff MS, Castellarnni AA, Zarbin MA. Endophthalmitis. Surv ophthalmol. 1998;43:193-224.
2. Peyman GA, Herbst R. Bacterial endophthalmitis: Treatment with intraocular injection of gentamicin and dexamethasone. Arch Ophthalmol. 1974;91:416-418.
3. Cottingham AJ, Forster RK. Vitrectomy in endophthalmitis: results of study using vitrectomy, injection of intraocular antibiotics, or a combination of both. Arch Ophthalmol. 1976;94:2078-2081.
4. Campochiaro PA, Conway BP. Aminoglycoside toxicity: A survey of retina specialists: Implication of postoperative endophthalmitis. Arch Ophthalmol. 1991;109:946-950.
5. Das T, Dogra MR, Gopal L, Jalali S, Kumar A, Malpani A, Natarajan S, Rajeev B, Sharma S. Postsurgical endophthalmitis. Diagnosis and management. Indian J Ophthalmol. 1995;43:103-116.
6. Endophthalmitis Vitrectomy Study Group. Results of the endophthalmitis vitrectomy study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol. 1995;113:479-496.
7. O'Day DM, Smith RS, Gregg CR, Turnbull PC, Head WS, Ives JA, Ho PC. The problem of Bacillus species infection with special emphasis on the virulence of Bacillus cereus. Ophthalmology. 1981;88:833-838.
8. Johnson MW, Doft BH, Kelsey SF, Barza M, Wilson LA, Barr CC, Wisniewski and the Endophthalmitis Vitrectomy Study Group. The Endophthalmitis Study. Relationship between clinical presentation and microbiologic spectrum. Ophthalmology. 1997;104:261-272.
9. Jalali S, Das T, Gupta S. Presumed Non infectious Endophthalmitis following Cataract Surgery. The Clinical Profile, Management Strategies and Treatment Outcome. J Cataract Refract Surg. 1996;22:1492-1497.
10. Sharma S, Jalali S, Adiraju MV, Gopinthan U, Das T. Sensitivity and Predictability of Vitreous Cytology, Biopsy and Membrane Filter Culture in Endophthalmitis. Retina. 1996;16:525-529.
11. Donahue SP, Kowalski RP, Jewart BH et al. Vitreous culture in suspected endophthalmitis. Biopsy or vitrectomy? Ophthalmology. 1993;100:452-455.
12. th ed. Philadelphia, CV Mosby Co., 1990;171-194.
13. Lohamann CP, Heeb M, Linde H, Gabel VP, Reischl U. Diagnosis of infectious endophthalmitis after cataract surgery by polymerase chain reaction. J Cat Refract Surg. 1998;24:821-826.
14. Lohmann CP, Linde HJ, Reischl U. Improved detection of microorganisms by polymerase chain reaction in delayed endophthalmitis after cataract surgery. Ophthalmology. 2000;107:1047-1052.
15. Sharma S, Das D, Anand R, Das T, Kannabiran C. Reliability of nested polymerase chain reaction in the diagnosis of bacterial endophthalmitis. Am J Ophthalmol. 2002;133: 142-144.
16. Han DP, Wisniewski SR, Wilson LA, Barza M, Vine AK, Doft BH, Kelsey SF, and the Endophthalmitis Vitrectomy Study Group. Spectrum and susceptibility of microbiologic isolates in the endophthalmitis vitrectomy study. Am J Ophthalmol. 1996;122:1-17.
17. Kunimoto DY, Das T, Sharma S, Jalali S, Majji AB, Gopinathan U, Athmanathan S, Rao TN, and the Endophthalmitis Research Group. Microbiologic spectrum and susceptibility of isolates: Part I. Postoperative endophthalmitis. Am J Ophthalmol. 1999;128:240-242.
18. Martin DF, Ficker LA, Aguilar HA, Gardner SK, Wilson LA. Vitreous cefazoline levels after intravenous injections. Effects of inflammation, repeated antibiotics doses, and surgery. Arch Ophthalmol. 1990;108:41-414.
19. Kern G, Alhalel A, Bartov E, Kitzes-Cohen R, Rubinstein E, Sergev S, Triester G. The intravitreal penetration of orally administered ciprofloxacin in humans. Invest Ophthalmol Vis Sci. 1991;32:2388-2392.
20. Aguilar HE, Meredith TA, Shaarawy A, Kincaid M, Dick J. Vitreous cavity penetration of ceftazidime after intravenous administration. Retina. 1995;15:154-159.
21. Hariprasad SM, Meiler W, Holz ER. Vitreous and aqueous penetration of orally administered gatiflaoxacin in humans. Arch Ophthalmol. 2003;121:345-350.
22. Anand Ar, Therese L, Madhavan HN. Spectrum of aetiological agents of postoperative endophthalmitis and antibiotic susceptibility of bacterial isolates. Indian J Ophthalmol. 2000;48:123-128.
23. Gupta A, Gupta V, Gupta A, Dogra MR, Pandav SS, Ray P, Chakraborty A. Spectrum and clinical profile of post cataract surgery endophthalmitis in North India. Indian J Ophthalmo. 2002;51:139-145.
24. Stenberg P Jr, Marin DF. Management of endophthalmitis in the post-Endophthalmitis Vitrectomy Study era. Arch Ophthalmol. 2001;119:754-755.
25. Irvine WD, Flynn HW Jr, Miller D, Pflugfelder SC. Endophthalmitis caused by gram-negative organisms. Arch Ophthalmol. 1992;110:1450-1454.
26. Mao LK, Flynn HW Jr, Miller D, Pflugfelder SC. Endophthalmitis caused by Staphyllococus aureus. Am J Ophthalmol. 1993;116:584-589.
27. Shah GK, Stein JD, Sharma S, Sivalingam A, Benson WE, Regillo CD, Brown GC, Tasman W. Visual outcome following the use of intravitreal steroids in the treatment of postoperative endophthalmitis. Ophthalmology. 2000; 107:486-489.
28. Das T, Jalali S, Gothwal VK, Sharma S, Naduvilath TJ. Intravitreal dexamethasone in exogenous bacterial endophthalmitis: results of a prospective randomized study. Br J Ophthalmol. 1999;83:1050-1055.
29. Kwak HW, D'Amico DJ. Evaluation of retinal toxicity and pharmocokinetics of dexamethasone after intravitreal injection. Arch Ophthalmol. 1992;110:259-266.
30. Park SS, Vallar RV, Hong CH, von Gunten S, Ruoff K, D'Amico DJ. Intravitreal dexamethasone effect on intravitreal vancomycin elimination in endophthalmitis. Arch Ophthalmol. 1999;117:1058-1062.
31. Coats MF, Peyman GA. Intravitreal corticosteriods in the treatment of fungal endophthalmitis. Retina. 1992;12:46-51.
32. Majji AB, Jalali S, Das T, Gopinathan U. Role of intravitreal dexamethasone in exogenous fungal endophthalmitis. Eye. 1999;13:660-665.
33. Doft BH, Kelsey SF, Wisniewski SR. Additional procedures after the initial vitrectomy or tap-biopsy in the Endophthalmitis Vitrectomy Study. Ophthalmology. 1998;105: 707-716.
34. Leopold IH. Doyne memorial lecture: Management of intraocular infection. Trans Ophthalmol Soc. UK 1971;91:575-610.
35. Wisniewski SR, hammer ME, Grizzard S, Kelsey SF, Everett D, Packo KH, Yarrin DL, Doft BH, and the EVS Study Group. An investigation of hospital charges related to the treatment of endophthalmitis in the Endophthalmitis Vitrectomy Study. Ophthalmology. 1997;104:739-745.